Marta Miarons

Barcelona, CT 08035, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Impact of UGT1A1*28 Allele on the Safety and Effectiveness of Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer: Real-World Evidence.

Impact of UGT1A1*28 Allele on the Safety and Effectiveness of Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer: Real-World Evidence.

Journal: Journal of clinical medicine

Published: December 10, 2025

Impact of fludarabine exposure on CAR T-cell outcomes in patients with large B-cell lymphoma.

Impact of fludarabine exposure on CAR T-cell outcomes in patients with large B-cell lymphoma.

Journal: Blood advances

Published: December 04, 2025

Impact of fludarabine exposure on CAR T-cell outcomes in patients with large B-cell lymphoma.

Impact of fludarabine exposure on CAR T-cell outcomes in patients with large B-cell lymphoma.

Journal: Blood advances

Published: December 04, 2025

Towards Personalized Lymphodepletion: A Population Pharmacokinetic Fludarabine Model in Patients Receiving CAR T-Cell Therapy.

Towards Personalized Lymphodepletion: A Population Pharmacokinetic Fludarabine Model in Patients Receiving CAR T-Cell Therapy.

Journal: Pharmaceutics

Published: October 27, 2025

Pharmacogenetic Implications for Antidepressant Therapy in Major Depression: A Systematic Review Covering 2019-2024.

Pharmacogenetic Implications for Antidepressant Therapy in Major Depression: A Systematic Review Covering 2019-2024.

Journal: Journal of clinical medicine

Published: June 18, 2025

A machine learning model exploring the relationship between chronic medication and COVID-19 clinical outcomes.

A machine learning model exploring the relationship between chronic medication and COVID-19 clinical outcomes.

Journal: International journal of clinical pharmacy

Published: February 20, 2025

Long-Term Effectiveness and Safety of Proactive Therapeutic Drug Monitoring of Infliximab in Paediatric Inflammatory Bowel Disease: A Real-World Study.

Long-Term Effectiveness and Safety of Proactive Therapeutic Drug Monitoring of Infliximab in Paediatric Inflammatory Bowel Disease: A Real-World Study.

Journal: Pharmaceutics

Published: November 06, 2024

[Translated article] Influence of the UGT1A1 gene polymorphism on treatment with sacituzumab govitecan. Narrative review.

[Translated article] Influence of the UGT1A1 gene polymorphism on treatment with sacituzumab govitecan. Narrative review.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: September 27, 2024

The Effect of Polymorphisms and Other Biomarkers on Infliximab Exposure in Paediatric Inflammatory Bowel Disease: Development of a Population Pharmacokinetic Model.

The Effect of Polymorphisms and Other Biomarkers on Infliximab Exposure in Paediatric Inflammatory Bowel Disease: Development of a Population Pharmacokinetic Model.

Journal: Paediatric drugs

Published: February 20, 2024

Therapeutic Drug Monitoring of antibiotic and antifungical drugs in paediatric and newborn patients. Consensus Guidelines of the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Paediatric Infectious Diseases (SEIP).

Therapeutic Drug Monitoring of antibiotic and antifungical drugs in paediatric and newborn patients. Consensus Guidelines of the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Paediatric Infectious Diseases (SEIP).

Journal: Anales de pediatria

Published: November 13, 2023

[Translated article] Therapeutic Drug Monitoring of antibiotic and antifungical drugs in paediatric and newborn patients. Consensus Guidelines of the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Paediatric Infectious Diseases (SEIP).

[Translated article] Therapeutic Drug Monitoring of antibiotic and antifungical drugs in paediatric and newborn patients. Consensus Guidelines of the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Paediatric Infectious Diseases (SEIP).

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: November 13, 2023

Is estimated exposure an accurate surrogate for measured fludarabine levels in patients with CAR T-cell therapy?

Is estimated exposure an accurate surrogate for measured fludarabine levels in patients with CAR T-cell therapy?

Journal: Blood advances

Published: October 20, 2023

Showing 1-12 of 39

Last Updated: 09/26/2026